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Abstract
Effective T cell responses can decisively influence the outcome of retroviral infection. However, what constitutes protective
T cell responses or determines the ability of the host to mount such responses is incompletely understood. Here we studied
the requirements for development and induction of CD4
+ T cells that were essential for immunity to Friend virus (FV)
infection of mice, according to their TCR avidity for an FV-derived epitope. We showed that a self peptide, encoded by an
endogenous retrovirus, negatively selected a significant fraction of polyclonal FV-specific CD4
+ T cells and diminished the
response to FV infection. Surprisingly, however, CD4
+ T cell-mediated antiviral activity was fully preserved. Detailed
repertoire analysis revealed that clones with low avidity for FV-derived peptides were more cross-reactive with self peptides
and were consequently preferentially deleted. Negative selection of low-avidity FV-reactive CD4
+ T cells was responsible for
the dominance of high-avidity clones in the response to FV infection, suggesting that protection against the primary
infecting virus was mediated exclusively by high-avidity CD4
+ T cells. Thus, although negative selection reduced the size and
cross-reactivity of the available FV-reactive naı ¨ve CD4
+ T cell repertoire, it increased the overall avidity of the repertoire that
responded to infection. These findings demonstrate that self proteins expressed by replication-defective endogenous
retroviruses can heavily influence the formation of the TCR repertoire reactive with exogenous retroviruses and determine
the avidity of the response to retroviral infection. Given the overabundance of endogenous retroviruses in the human
genome, these findings also suggest that endogenous retroviral proteins, presented by products of highly polymorphic HLA
alleles, may shape the human TCR repertoire that reacts with exogenous retroviruses or other infecting pathogens, leading
to interindividual heterogeneity.
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Introduction
Adaptive immunity to viral infection relies on appropriate
activation of T cells by complexes of viral peptides with MHC
molecules. The host MHC haplotype, the nature of the viral
peptide targeted and the T cell receptor (TCR) repertoire of
responding T cells are three interconnected parameters that play a
decisive role in the outcome of infection. Indeed, the MHC is the
predominant genetic factor affecting susceptibility to many
infectious diseases [1–4]. For example, the HLA locus shows the
strongest genetic association with control of HIV infection, with
certain HLA alleles having been consistently found to confer a
protective advantage [3,5,6]. Although the precise underlying
mechanism is not completely understood, T cell responses
restricted by protective HLA/MHC alleles often comprise narrow-
er TCR repertoires, dominated by public TCR sequences, and
exhibit higher magnitude, avidity or depth, and thus greater
contribution to HIV or SIV control, than those restricted by non-
protective HLA/MHC alleles [7–9].
Bias in the use of certain TCRVa (Va) or TCRVb (Vb) chains
has been frequently observed in the T cell response to several
antigenic epitopes, and public T cell responses with identical or
similar TCRs have been found to dominate the response of
different individuals to a given epitope. Skewed TCR usage has
often correlated with higher functional avidity to a given antigenic
epitope, and, in diverse systems, also translated into more efficient
protection against infection [10–12]. Despite the potential
importance in cellular immunity to infection, however, the
mechanisms by which TCR biases (and particularly high-avidity
T cell responses to viral infections) are generated and maintained
remains incompletely understood. The mechanisms leading to bias
in the T cell response will vary considerably depending on the
antigenic peptide and MHC combination. TCR repertoire bias
can be generated during thymic selection, leaving only certain Va
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generated at the initiation of the immune response, where clones
using particular Va or Vb chains may have a recruitment or
proliferative advantage and can quickly dominate the response
[10]. Lastly, bias can also be generated during chronic viral
infection either due to preferential maintenance of certain T cell
clones or differential margins for cross-reactivity with viral escape
mutations [10] or by prior or concurrent infection with
heterologous viruses, sharing cross-reactive epitopes [13].
We have previously describedtheTCRb-transgenicstrainEF4.1,
which generates increased frequencies of CD4
+ T cells reactive with
the H2-A
b-restricted env122-141 epitope of Friend murine leukemia
virus (F-MLV) [14]. Virus-specific EF4.1 CD4
+ T cells show bias in
the use of endogenous Va2 chains in their response to infection with
Friend virus (FV), a retroviral complex of F-MLV and spleen focus-
forming virus (SFFV) [14,15]. Use of Va2 chains by virus-specific
CD4
+ T cells creates higher avidity for the same epitope than use of
other Va chains, and although they represent a minority in the
naı ¨ve repertoire, high-avidity Va2 T cells become the dominant
subset at the peak of the response [15]. Here we have examined the
potential mechanisms underlying the formation of TCR repertoire
diversity in this system, which might be responsible for the high-
avidity response to FV infection. We have found that a thymic
selection event was necessary for the dominance of Va2v i r u s -
specific CD4
+ T cells during the response to FV infection. Selection
of virus-specific CD4
+ T cells was mediated by a self peptide
encoded by an endogenous retrovirus with substantial similarity to
F-MLV. Unexpectedly, despite deleting a sizeable fraction of virus-
specific CD4
+ T cells, negative selection by this endogenous
retrovirus was necessary for a predominantly high-avidity response
to FV infection.
Results
Higher functional avidity of Va2 F-MLV env122-141-specific
CD4
+ T cells
On average, 4% of EF4.1 CD4
+ T cells in virus-naı ¨ve mice
react with the env122-141 peptide, of which approximately 25%
stain positive with the anti-Va2 monoclonal antibody B20.1
[14,15]. Va2 env-specific CD4
+ T cells were previously [14,15]
found to be .30-fold more sensitive than non-Va2 T cells to
stimulation with a 20-mer env122-141 peptide spanning the core
env128-134 epitope [16]. This higher avidity of Va2 CD4
+ T cells
was not due to recognition of the core epitope-flanking residues by
this family of Va chains, as has been described for other TCR –
epitope combinations [17], since it was maintained against a series
of N-terminal truncated peptide epitopes (Figure S1A). Thus, Va2
CD4
+ T cells would recognize with higher avidity all the nested
peptides of variable lengths likely to be generated during in vivo
processing of env [18].
To examine whether the polyclonal Va2 CD4
+ T cell
population displayed higher affinity for F-MLV env-derived
epitopes even at the clonal level, we generated hybridoma cell
lines from primary EF4.1 CD4
+ T cells stimulated in vitro with
either a low (10
27 M) or a high (10
25 M) peptide dose. In
agreement with our previous findings [14,15], 71% (20/28) and
30% (9/30) of hybridoma cell lines derived from CD4
+ T cells
stimulated with the low or high peptide dose, respectively, were
Va2
+. Similarly to primary EF4.1 CD4
+ T cells, randomly selected
Va2 T cell hybridomas were more sensitive to stimulation with all
the peptides tested than non-Va2 ones, irrespective of whether a
high or low peptide dose was used for their generation (Figure
S1B). Thus, the higher avidity of Va2 CD4
+ T cells for F-MLV
env-derived epitopes was also observed at the level of individual
clones.
To assess whether low-avidity F-MLV env-reactive CD4
+ T
cells were characterized by expression of any particular family of
endogenous Va chains, we screened env122-141-specific non-Va2
CD4
+ T cells for expression of Trav transcripts encoding different
Va families. Although this analysis indicated enrichment for
Trav9 expression (encoding Va3), only a small percentage of
env122-141-reactive non-Va2C D 4
+ T cells stained positive with
the anti-Va3.2 monoclonal antibody RR3-16 (unpublished data),
and only 2 out of 4 F-MLV env-reactive non-Va2Tc e l l
hybridomas were positive for Va3.2 (Table S1). However, Va3.2
is used preferentially in CD8
+ T cells in B6 mice, whereas the
other three of the four expressed Va3 family members are
preferentially expressed in CD4
+ T cells [19]. It was therefore
possible that env122-141-reactive non-Va2C D 4
+ T cells that did
not stain positive with the RR3-16 antibody were also expressing
Va3. Indeed, cloning and sequencing of expressed endogenous
Trav genes from theses hybridomas revealed that they were all
members of the Trav9 family (Table S1). Thus, similarly to
selective usage of Va2 chains in high-avidity cells, low-avidity F-
MLV env122-141-reactive CD4
+ T cells selectively used Va3
chains. However, in the absence of a Va3-specific antibody that
can detect all Va3 family members, these cells were referred to
here as non-Va2 cells.
Lastly, we tested whether biased use of Va2 chains also
characterized the response of non-transgenic CD4
+ T cells to F-
MLV env. CD4
+ T cells from wild-type (wt) C57BL/6 (B6) mice 7
days post FV infection were stained with an env123-141-presenting
tetramer (A
b-env123-141). In comparison with a control tetramer,
staining with A
b-env123-141 tetramer identified a measurable
population of env122-141-specific CD4
+ T cells in all infected mice
(Figure 1A), in agreement with published data [20,21]. FV
infection had no impact on the frequency of Va2 cells in naı ¨ve
(CD44
lo) and total memory (CD44
hi) CD4
+ T cells (15% and 12%,
respectively), with minimal variation between individual mice




+ T cells varied considerably between 4% and 23%.
These results revealed substantial deviation in Va2 usage in A
b-
Author Summary
Our immune systems defend against viral infection.
However, the immune response to a virus often differs
substantially between individuals, as does the outcome of
infection. The antiviral immune response relies on recog-
nition of viral proteins by T lymphocytes using T cell
antigen receptors (TCRs). TCRs are created randomly in an
individual and each T lymphocyte has a different TCR. T
lymphocytes with TCRs that recognize our own (self)
proteins are removed during development, to prevent
autoimmunity. Our cells can also make proteins that
belong to endogenous retroviruses (ERVs), relics of
ancestral retroviral infection that accumulated during
evolution to constitute a large proportion of our genomes.
The impact of ERVs on lymphocyte development and the
subsequent influence on antiviral immunity is incomplete-
ly understood. Here, we use a mouse model to investigate
this link and show that the T lymphocyte response to
exogenous retrovirus infection is heavily influenced by an
ERV. Surprisingly, we find that ERVs do not always have a
negative impact on immunity, and in our model they
improve the sensitivity with which T lymphocytes react to
retroviral infection. This work may thus provide a basis for
the understanding of the heterogeneity in immunity to
retroviral infections in genetically diverse individuals.
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+ CD4
+ T cells from the same usage in total
CD4
+ T cells, but also indicated substantial heterogeneity.
However, this particular tetramer is known to bind only some
env122-141-specific T cell clones but not others [14,22]. Further-
more, at the peak of their response, env122-141-specific CD4
+ T cell
reversibly downregulate up to 70% of their surface TCR [15,23],
which could prevent tetramer binding. Indeed, combining
adoptive transfer of EF4.1 CD4
+ T cells and tetramer staining
revealed that A
b-env123-141 tetramer staining was restricted to
env122-141-reactive CD4
+ T cells with above-average TCR levels,
independently of Va usage, and TCR re-expression improved
tetramer staining (Figure 1C–F). Thus, detection of env122-141-
reactive CD4
+ T cells by A
b-env123-141 tetramer staining was
eclipsed by in vivo antigen-induced TCR downregulation. Collec-
tively, these results both validated and necessitated the use of
env122-141-reactive EF4.1 CD4
+ T cells that can be indelibly
identified, independently of A
b-env123-141 tetramer binding, to
study the requirements for induction of a high-avidity CD4
+ T cell
response to F-MLV env.
Deletion of F-MLV env122-141-specific CD4
+ T cells by
Emv2-encoded env
F-MLV env122-141-reactive CD4
+ T cells in EF4.1 mice have a
naı ¨ve phenotype [14], and it was therefore likely that the F-MLV
env122-141-reactive TCR repertoire and associated avidity differ-
ences were the result of thymic selection events. We searched the
mouse proteome for the presence of self-derived epitopes with
homology to F-MLV env122-141. This approach identified the
single-copy endogenous ecotropic MLV at the Emv2 locus [24].
Emv2 shares 80% homology with F-MLV at the DNA sequence
level, and although it represents a full-length provirus, it is unable
to produce infectious particles due to a single inactivating point-
mutation in the pol gene [24]. Nevertheless, Emv2 has full potential
for env expression, and, importantly, the env122-141 epitope is
almost identical between Emv2 and F-MLV, with the exception of
a Y instead of an L at position 128 (Figure S2A). For this reason,
Emv2 and F-MLV env-derived epitopes were referred to here as
env122-141Y and env122-141L, respectively. Position 128, together
with 129 and 133, have been previously mapped as important
Figure 1. Detection of env-specific CD4
+ T cells by A
b-env123-141 tetramer eclipsed by antigen-induced TCR downregulation. (A) A
b-
hCLIP (control) or A
b-env123-141 tetramer staining in total CD4
+ T cells isolated from the spleen of wild-type B6 mice 7 days post FV infection. Plots are
representative of 7 mice. (B) Frequency of Va2 cells in either bulk naı ¨ve (CD44




+ T cells from
the same FV infected mice. Horizontal short lines in naı ¨ve and memory subsets denote the mean frequency of Va2 cells in the same populations from
uninfected mice. Each symbol represents an individual mouse. (C–F) CD45.1
+ EF4.1 CD4
+ T cells were adoptively transferred into wild-type B6
recipients that were infected with FV the same day. (C) A
b-env123-141 tetramer staining in host (CD45.1
2) or donor (CD45.1
+) CD4
+ T cells according to
TCRa or TCRb staining. Gates in donor CD4
+ T cells are set around the median TCRa and TCRb staining, respectively. (D) Percentage of A
b-env123-141
tetramer
+ cells in donor CD4
+ T cells with TCRb (left) or TCRa (right) staining below or above the median. (E) A
b-hCLIP or A
b-env123-141 tetramer
staining in host or donor CD4
+ T cells from the same recipients assessed directly ex vivo (top) or following 3-day in vitro culture in the absence of
antigenic stimulation (bottom). (F) Percentage of A
b-env123-141 tetramer
+ cells in donor CD4
+ T cells before and after in vitro culture. In (D) and (F) each
symbol represents an individual mouse from one of two experiments.
doi:10.1371/journal.ppat.1002709.g001
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donor of the TCRb chain transgene used in EF4.1 mice [16].
We next investigated whether or not Emv2 could be involved in
T cell selection. In vitro stimulation with the env124-138Y epitope
activated a fraction of EF4.1 CD4
+ T cells, which was however
smaller than the fraction activated by the env124-138L epitope
(Figure 2A). As EF4.1 mice generate a polyclonal TCR repertoire,
it was unclear whether the same CD4
+ T cells could respond to
both epitopes. However, analysis of env124-138L-reactive T cell
hybridomas revealed the same TCR could be activated by both
env124-138L and env124-138Y epitopes, albeit less potently by the
latter peptide (Figure 2B). Thus, F-MLV env124-138-reactive TCRs
have the potential to recognize Emv2 env. This analysis also
revealed that Emv2 was not causing complete tolerance of either
env124-138L or env124-138Y epitopes. We then confirmed that Emv2
was expressed in primary and secondary lymphoid organs. Using
primers specific to the spliced env mRNA that could distinguish
between genuine transcripts and contaminating genomic DNA,
Emv2 was found to be expressed at low levels in the majority of
mice tested (Figure 2C). This low level of expression was further
confirmed by comparison with a newly-generated B6 congenic
strain lacking Emv2 (Figure S3). To evaluate the extent of Emv2-
mediated deletion of env-reactive CD4
+ T cells more directly, we
generated B6-Emv2
2/2 EF4.1 mice and compared them with
Emv2-expressing EF4.1 mice. Emv2-deficient EF4.1 mice con-
tained a significantly higher frequency of env124-138L-reactive
CD4
+ T cells than Emv2-sufficient EF4.1 mice, with Emv2, when
present, being responsible for the deletion of approximately 35%
of these cells (Figure 2D). Thus, albeit low, expression of Emv2 in




+ T cell repertoire retains full
antiviral activity
Emv2-mediated deletion of a proportion of env124-138L-reactive
EF4.1 CD4
+ T cells suggested that Emv2 may impinge on
resistance to FV infection. We therefore examined the possible
effect of Emv2 expression on FV control. Firstly, we infected non-
transgenic B6 and Emv2-deficient B6 mice and measured the levels
of infected cells in the spleen. B6 mice are relatively resistant to FV
infection due to genetic resistance at the Fv2 locus and due to
mounting a strong adaptive immune response [1,25], resulting in
control of the infection by the third week. Percentages of FV-
infected (glyco-Gag
+) erythroid precursor (nucleated Ter119
+) cells
were significantly lower in B6-Emv2
2/2 mice than in wt
counterparts at day 7 of infection (Figure 3A). Nevertheless, wt
B6 mice effectively controlled FV infection to levels comparable
with those in B6-Emv2
2/2 mice by the second week of infection
(Figure 3A). Thus, Emv2 deficiency did not extensively increase the
natural resistance of B6 mice to FV infection.
The modest increase in resistance to FV infection in B6-
Emv2
2/2 mice suggested that this low Emv2 expression was
immunologically relevant, but did not indicate if any arm of the
adaptive immune response was affected. We thus measured the
FV-specific CD4
+ T cell, CD8
+ T cell and antibody responses in
these mice. In contrast to the MHC class II-restricted env122-141L
epitope, the FV-derived MHC class I-restricted epitopes that have
been described do not share extensive homology or cross-reactivity
with those derived from Emv2 [26–28]. We examined the CD8
+ T




+ T cells, irrespective of antigen specificity, in
the spleens of B6 and B6-Emv2
2/2 mice 7 days post FV infection




+ T cells, suggesting they mounted a CD8
+
T cell response of similar magnitude (Figure S4A). We further
measured the CD8
+ T cell response to the immunodominant D
b-
restricted epitope from the leader sequence gPr80gag85-93 encoded
by the F-MuLV gag gene [28]. CD8
+ T cells specific to the
gPr80gag85-93 epitope display strong bias for the use of Va3.2 and
Vb5.2 in combination, which allows their identification by flow
cytometry [29]. Expectedly, FV infection led to an increase in the
percentage of Va3.2
+Vb5.2
+ cells in antigen-experienced
(CD44
hi), but not naı ¨ve (CD44
lo) CD8
+ T cells (Figure S4B).





was comparable in B6 and B6-Emv2
2/2 mice 7 days post FV
infection (Figure S4B).
We next examined the FV-specific antibody response of B6 and
B6-Emv2
2/2 hosts. As FV-neutralizing antibodies are not readily
Figure 2. Emv2 selects against a fraction of env124-138L-specific CD4
+ T cells. (A) Dilution of prior CFSE label by primary EF4.1 CD4
+ T cells
incubated for three days in vitro in the absence of peptide stimulation (-) or in the presence of 10
25 M env124-138L or env124-138Y peptides. Numbers
within the plots denote the percentage of CFSE
2 cells and are representative of 4 mice per condition. (B) IL-2 production by three env124-138L-specific
hybridoma T cell lines in response to in vitro stimulation with the same peptides at 5610
26 M. (C) Emv2 transcription, relative to Hprt transcription, in
thymi (Th) and spleens (Sp) of wild-type B6 or Emv2-deficient B6 mice (B6-Emv2
2/2). Each symbol is an individual mouse. The dashed line represents
the limit of detection. (D) Frequency of env124-138L-specific cells in primary CD4
+ T cells from B6 (B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv2
2/2)
EF4.1 mice. Data are the means 6 SEM (n=9) from 3 experiments.
doi:10.1371/journal.ppat.1002709.g002
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titers of antibodies that were able to bind F-MLV-infected cells
(Figure S4C). On day 7 post FV infection all mice produced both
IgG and IgM F-MLV-infected cell-binding antibodies that could
be measured by flow cytometry (unpublished data). However, titers of
these antibodies were low at this early time-point and in a
proportion of FV-infected mice they were below 50, a value that
we set as the detection limit (Figure S4C). Importantly, serum
titers of both IgG and IgM F-MLV-infected cell-binding
antibodies were similar between B6 and B6-Emv2
2/2 hosts (Figure
S4C).
Lastly, the frequency of A
b-env123-141 tetramer
+ CD4
+ T cells as
well as the frequency of Va2 cells within this population was highly
variable between individual mice and as a result not statistically
different between groups of B6 and B6-Emv2
2/2 hosts on day 7
post FV infection (Figure S4D). However, staining with the A
b-
env123-141 tetramer may have underestimated the frequency of
env122-141L-reactive CD4
+ T cells (Figure 1) and it was also
possible that env122-141L-reactive CD4
+ T cells selected in the
presence or absence of Emv2 expressed TCRs with distinct A
b-
env123-141 tetramer-binding properties. Furthermore, virus-specific
CD4
+ T cells can mediate both direct and indirect protection
against FV infection [15,23,30], and env122-141-specific CD4
+ T
cells have been shown to mediate direct cytotoxic activity [31]. It
was thus uncertain whether weakened immunity in Emv2-
expressing mice was directly linked to a potentially less effective
CD4
+ T cell response. We therefore examined the effect of Emv2
expression on the FV-specific CD4
+ T cell response functionally
and directly. To this end, equal numbers of Emv2-selected or -
nonselected EF4.1 CD4
+ T cells were transferred into the same
type of host. This approach ensured that only donor EF4.1 CD4
+
T cells differed with respect to exposure to Emv2. Surprisingly, the
two types of donor CD4
+ T cells provided comparable and almost
complete protection of wild-type B6 hosts, at the peak of FV
replication on day 7 post infection (Figure 3B, C). To rule out that
differences in antiviral activity between the two types of donor
CD4
+ T cells were not missed because this activity was already
maximal, we have additionally used B6.A-Fv2
s hosts, expressing
the susceptibility allele at the Fv2 locus, which confers susceptibility
to FV infection by enhancing proliferation of infected erythroid
Figure 3. Emv2-selected CD4
+ T cells retain full antiviral activity. (A) Mean frequency (6 SEM, n=8–19) of FV-infected (glyco-Gag
+) Ter119
+
cells in the spleens of FV-infected B6 or Emv2-deficient B6 mice (B6-Emv2
2/2). (B–C) CD4
+ T cells isolated from either B6 (B6-EF4.1) or Emv2-deficient
B6 (B6-EF4.1 Emv2
2/2) EF4.1 mice were adoptively transferred into B6 or B6.A-Fv2
s recipients that were infected with FV the same day and analyzed 7
days later. (B) Flow cytometric example of FV-infected Ter119
+ cells from B6 recipients and (C) frequency of FV-infected cells in Ter119
+ cells from the
spleens of B6 or B6.A-Fv2
s recipients of CD4
+ T cells. Control B6 and B6.A-Fv2
s mice that received no CD4
+ T cells (-) are also included. Each symbol is
an individual mouse. (D) Spleen index (left) and RBC count (right) of B6-Rag1
2/2Fv2
s mice that were infected with FV and either received the same day
CD4
+ T cells isolated from either B6 (B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv2
2/2) EF4.1 mice or no cells (-). Each symbol is an individual mouse
analyzed 3 weeks post infection. (E) Titers of FV-neutralizing antibodies during the course of FV infection (left) and titers of F-MLV-infected cell-
binding IgG (middle) and IgM (right) 7 days post FV infection, in the sera of B6-Tcra
2/2 mice that either received CD4
+ T cells isolated from either B6
(B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv2
2/2) EF4.1 mice or no cells (-) the day of the infection. Dashed lines represent the limit of detection.
Data are the means 6 SEM (n=11–12) from 2 experiments.
doi:10.1371/journal.ppat.1002709.g003
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+ T cells provided
significant, suboptimal and, importantly, comparable protection in
B6.A-Fv2
s hosts, at the peak of FV replication and expansion of
infected erythroid precursors on day 7 post infection in this strain
(Figure 3C). Thus, Emv2-mediated selection did not impair the
antiviral activity of CD4
+ T cells exerted in wt hosts. To further
examine direct CD4
+ T cell-mediated protection we transferred
equal numbers of Emv2-selected or -nonselected EF4.1 CD4
+ T
cells into T and B cell-deficient Rag1
2/2 Fv2
s hosts. Both types of
donor CD4
+ T cells were similarly protective against severe FV-
induced splenomegaly (Figure 3D) that otherwise develops in these
hosts [15]. In addition, the two types of donor CD4
+ T cells caused
comparable levels of anemia in these T and B cell -deficient hosts
(Figure 3D), which results from bone marrow pathology [14].
Lastly, FV-neutralizing antibodies were similarly and efficiently
induced in T cell-deficient Tcra
2/2 hosts by transfer of either type
of donor CD4
+ T cells, although they were slightly, but not
significantly higher in hosts of Emv2-nonselected CD4
+ T cells on
day 7 post infection (Figure 3E). Nevertheless, at this time-point,
the two types of donor CD4
+ T cells induced comparable titers of
IgG or IgM antibodies that were able to bind F-MLV-infected
cells, which also included antibodies potentially mediating
antibody-dependent cell-mediated cytotoxicity (Figure 3E). Col-
lectively, these results demonstrated that despite selecting against a
significant fraction of env124-138L-reactive CD4
+ T cells, Emv2
expression did not compromise CD4
+ T cell function against FV
infection.
Selection by Emv2 promotes a higher-avidity response to
F-MLV
Retention of full CD4
+ T cell-mediated antiviral activity, despite
deletion of over a third of env124-138L-reactive CD4
+ T cells in
Emv2-expressing mice, suggested that the deleted cells were not
contributing to immunity against FV infection. We therefore
assessed the impact of Emv2 expression on both the magnitude and
composition of the CD4
+ T cell response to FV. Equal numbers of
EF4.1 CD4
+ T cells from either Emv2-sufficient or -deficient donor
B6 mice, positive for CD45.2 (encoded by the Ptprc
2 allele), were
adoptively transferred into Ptprc
1/2 syngeneic B6 recipients that
were positive for both CD45.1 and CD45.2. Recipient mice were
infected with FV on the day of T cell transfer and FV-responding
donor CD4




cells (Figure S5). Consistent with increased precursor frequency in
Emv2-deficient donor mice, significantly higher numbers of total
responding CD4
+ T cells could be recovered at the peak of the
response from secondary recipients that received Emv2-nonselect-
ed than those that received Emv2-selected donor CD4
+ T cells
(Figure 4A). Notably, the two types of donor CD4
+ T cells
generated comparable numbers of high-avidity responding CD4
+
T cells, and the numerical increase in total numbers of responding
CD4
+ T cells from Emv2-nonselected donors was due to
significantly higher expansion of low-avidity non-Va2 responding
CD4
+ T cells from these donors in comparison with the expansion
of non-Va2 responding CD4
+ T cells from Emv2-selected donors
(Figure 4A). As a result, peak expansion of Emv2-selected CD4
+ T
cells was dominated by high-avidity Va2 CD4
+ T cells, whereas
that of Emv2-nonselected CD4
+ T cells was dominated by low-
avidity non-Va2 CD4
+ T cells (Figure 4B, C). Thus, Emv2
expression converted a predominantly low-avidity response to FV
to a predominantly high-avidity response.
Emv2-encoded env preferentially deletes non-Va2 CD4
+ T
cells
The shift from a predominantly Va2 response of Emv2-selected
CD4
+ T cells to a predominantly non-Va2 response of Emv2-
nonselected CD4
+ T cells could be the result of Emv2-induced
modulation of either the relative frequency in the naı ¨ve repertoire
of the two subsets of env124-138L-reactive CD4
+ T cells, or their
relative avidity for env124-138L (or both). We first measured the
overall functional avidity to env124-138L of EF4.1 CD4
+ T cells
selected with or without Emv2 as an indicator of potential avidity
repertoire changes. Surprisingly, although the presence of Emv2
reduced the precursor frequency of env124-138L-reactive CD4
+ T
cells, it had no effect on the avidity with which they responded to
env124-138L stimulation (Figure 5A). This result suggested that
Emv2-mediated selection either affected high- and low-avidity cells
similarly, or that potential loss of higher-avidity T cells was
compensated by an increase in average avidity of the remaining T
cells. To examine whether Emv2 preferentially selected against
high-avidity env124-138L-reactive cells, we measured their frequen-
cy separately in either Va2 or non-Va2 CD4
+ T cells from EF4.1
mice. Notably, Emv2 expression significantly reduced the frequen-
cy of non-Va2, but not Va2 env124-138L-reactive cells in EF4.1
CD4
+ T cells (Figure 5B), indicating that it only selected against
Figure 4. Emv2-selected CD4
+ T cells mount a predominantly high-avidity response. (A–C) CD45.2
+ (Ptprc
2/2) CD4
+ T cells isolated from
either B6 (B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv2
2/2) EF4.1 donor mice were adoptively transferred into Ptprc
1/2 B6 recipients that were





+ T cells isolated from the spleens of recipient mice according to donor type. (B) Flow cytometric example and (C) frequency of
high-avidity Va2 cells in responding CD4
+ T cells according to donor type. In (A) and (C) each symbol is an individual mouse.
doi:10.1371/journal.ppat.1002709.g004
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+ T cells. Correspondingly, the avidity of Va2 CD4
+
T cells to env124-138L was not altered by Emv2 expression, whereas
the avidity of non-Va2 CD4
+ T cells was 3-fold higher in the
absence than in the presence of Emv2 (Figure 5C). Nevertheless,
non-Va2 CD4
+ T cells from Emv2-deficienct mice still displayed
lower avidity than Va2 CD4
+ T cells from either Emv2-deficienct
or -sufficient mice (Figure 5C).
To test whether Emv2-mediated changes in the frequency and
avidity for env124-138L of non-Va2C D 4
+ T cells could account
for the dominance of this subset in the in vivo response to FV of
Emv2-nonselected CD4
+ Tc e l l s ,w ee x a m i n e dt h ein vitro response
of Emv2-selected or -nonselected primary naı ¨ve EF4.1 CD4
+ T
cells to env124-138L stimulation. As a result of differences in initial
frequency and functional avidity between virus-naı ¨ve Va2 and
non-Va2 env122-141-specific cells, the composition of the respond-
ing population varied according to the amount of env122-141
presentation [14] and Va2 T cells dominated the response at
doses lower than 10
27 M (Figure 5D). Importantly, this
percentage of Va2 cells was significantly lower at all peptide
doses in CD4
+ T cells selected in the absence than in the presence
of Emv2 (Figure 5D), demonstrating that selection by this single
provirus heavily influenced the clonal composition of env124-138L-
reactive CD4
+ T cells, in favor of high-avidity cells. We further
confirmed that this effect of Emv2 expression of reducing the
overall frequency of env124-138L-reactive cells, but significantly
increasing the percentage of high-avidity Va2 cells in the
env124-138L-reactive population was already evident in
CD4
+CD8
2 thymocytes (Figure S6), consistent with a thymic,
rather than peripheral event.
Preferential deletion by Emv2 of non-Va2 CD4
+ T cells, which
had low avidity for F-MLV env124-138L raised the possibility that
these cells may have been cross-reactive with Emv2-encoded
env124-138Y. Indeed, lack of Emv2 expression in EF4.1 mice had a
small, non-significant effect on env124-138Y-reactive Va2 CD4
+ T
cells, but caused a significant 3.5-fold increase in the frequency of
env124-138Y-reactive non-Va2 CD4
+ T cells (Figure 5E). Further-
more, Va2 CD4
+ T cells from either Emv2-deficient or -sufficient
EF4.1 mice could only react with env124-138Y at the highest dose of
10
25 M, whereas non-Va2 CD4
+ T cells from Emv2- deficient
mice were markedly more sensitive to env124-138Y than those from
Emv2-sufficient mice (and as sensitive as Va2 CD4
+ T cells to
env124-138L) (Figure 5F). Together, these findings indicated that
Emv2 expression was not affecting env124-138L-reactive Va2 CD4
+
T cells because they displayed low avidity for env124-138Y, but was
deleting a significant proportion of non-Va2 CD4
+ T cells that
could react with either env124-138L or env124-138Y.
Figure 5. Emv2 preferentially selects against non-Va2 env-specific CD4
+ T cells. (A) Dose-response to env124-138L stimulation of CD4
+ T cells
isolated from either B6 (B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv2
2/2) EF4.1 mice. (B) Frequency of env124-138L-specific cells in Va2 or non-Va2
primary CD4
+ T cells from the same donors. (C) Functional avidity of Emv2-selected (B6-EF4.1) or -nonselected (B6-EF4.1 Emv2
2/2) EF4.1 CD4
+ T cells
for env124-138L. (D) Frequency of Va2 cells in env124-138L-specific CD4
+ T cells from the same donors as a function of peptide concentration. (E)
Frequency of env124-138Y-specific cells in Va2 or non-Va2 primary CD4
+ T cells from the same donors. (F) Functional avidity of Emv2-selected (B6-
EF4.1) or -nonselected (B6-EF4.1 Emv2
2/2) EF4.1 CD4
+ T cells for env124-138Y. Numbers in (C) and (F) represent the ED50. Data in (A–F) are the means 6
SEM (n=9–12) of 18-hr stimulations from 3 experiments.
doi:10.1371/journal.ppat.1002709.g005
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+ T cell repertoire depth by
Emv2
Although EF4.1 CD4
+ T cells selected by Emv2 mounted high-
avidity responses to the index env124-138L sequence in vitro, and to
FV infection in vivo, and retained full antiviral activity, counter-
selection of env124-138Y-reactive clones indicated that this reper-
toire would be less able to respond to viral escape mutations, and
especially to an L128Y mutation. To extend these findings, we
used another variant of env, which differed from F-MLV env in
two of the three putative TCR-binding residues. This variant has
Y and S in positions 128 and 129, respectively (referred to as
env124-138YS) and is a naturally-occurring functional form of
ecotropic env, encoded by the Fv4 locus in certain strains and
species of mouse, other than the B6 strain [32,33]. Again, a very
small fraction of EF4.1 Va2 CD4
+ T cells could react to
env124-138YS, regardless of the presence or absence of Emv2
(Figure 6A). In contrast, lack of Emv2 led to a 7-fold increase in the
frequency of env124-138YS-reactive EF4.1 non-Va2 CD4
+ T cells,
which now made a sizable fraction (Figure 6A). Thus, non-Va2
CD4
+ T cells from Emv2-deficient EF4.1 mice could react with the
index sequence and the two env variants and with high avidity to
env124-138Y, suggesting that Emv2-mediated selection significantly
reduced the ability of CD4
+ T cells, at the population level, to
recognize these env variants.
This analysis of polyclonal cells from Emv2-deficient EF4.1 mice
did not reveal whether the same T cell could react to all three env
variants or if env124-138L-, env124-138Y- and env124-138YS-reactive
non-Va2 CD4
+ T cells were distinct. We therefore tested the
reactivity of hybridoma cell lines generated from env124-138L-
reactive EF4.1 CD4
+ T cells that developed either in the presence
or the absence of Emv2 expression to other env variants. Similarly
to non-Va2 CD4
+ T cell hybridomas from Emv2-sufficient donors,
all 4 non-Va2 CD4
+ T cell hybridomas tested from Emv2-deficient
donors used members of the TCRVa3 family (encoded by the
Trav9 gene family; Table S2). Notably, neither Emv2-selected nor -
nonselected env124-138L-reactive non-Va2 CD4
+ T cell hybrid-
omas responded to env124-138Y more potently than Va2 CD4
+ T
cell hybridomas from the same donor strain, and only 1 out of 4
had a measureable response to env124-138YS (Figure 6B, C). These
findings suggested that the env124-138L-reactive non-Va2 CD4
+ T
cells that developed in Emv2-deficient EF4.1 mice were largely
distinct from env124-138Y- and env124-138YS-reactive T cells in the
same mice. They also indicated that env124-138L-reactive non-Va2
CD4
+ T cells were not inherently more cross-reactive than env124-
138L-reactive Va2 CD4
+ T cells at the clonal level.
To gain a more detailed view of the depth, defined here as the
ability to tolerate epitope mutations, of env124-138L-reactive Va2
or non-Va2 TCRs, we screened Emv2-selected or -nonselected
env124-138L-reactive T cell hybridomas for reactivity against a
library of env126-138 peptide variants carrying all possible single
mutations in each of the amino acid residues in positions 128, 129
and 133 (Figure S7). Amino acids that elicited at least 40% of the
maximal response were listed in the order they were preferred by
the individual TCRs (Figure 7). All Va2 T cell hybridomas
displayed strong preference for L at position 128 and also
recognized similar amino acids with hydrophobic side chains,
namely F, I, M and V, but not the less hydrophobic Y (Figure 7A).
Va2 T cell hybridomas also showed strong preference and
specificity for the amino acid residues of the index sequence
against which they were derived, T or highly similar S at position
129, and N at position 133 (Figure 7B, C). Overall, the depth of
Va2 T cell hybridomas was highly homogeneous and unaffected
by Emv2 expression. In contrast to Va2 T cell hybridomas, and as
expected by their low avidity for the index env124-138L sequence,
none of the non-Va2 T cell hybridomas derived from Emv2-
deficient mice displayed strong preference for L at position 128
(Figure 7A). The latter hybridomas did, however, respond strongly
to env variants with a different amino acid residue at this position,
most frequently V or I, or in the case of clone E2H10 the
unrelated S (Figure 7A). Non-Va2 T cell hybridomas selected by
Emv2 were also heterogeneous, with two clones showing similar
preference and specificity for V or I, and two other clones showing
much wider reactivity to at least 10 different amino acid residues,
including L (Figure 7A). Furthermore, the low reactivity to the
index env124-138L sequence of two of the four non-Va2 T cell
hybridomas derived from Emv2-deficient mice, but not those
derived from Emv2-sufficient mice, could be enhanced by
substitutions at another position (C for clone E2H10, and S or
T for clone E2L18, instead of N at position 133) (Figure 7C). Non-
Va2 T cell hybridomas that could recognize L at position 128 also
preferred the amino acid residue of the index env124-138L sequence
at the two other positions (T and N for positions 129 and 133,
respectively) (Figure 7B, C). Collectively, these results confirmed
the differential preference for L at position 128 between Va2 and
Figure 6. Cross-reactivity of individual Va2 or non-Va2 CD4
+ T cells. (A) Frequency of env124-138YS-reactive cells in Va2 or non-Va2 CD4
+ T
cells isolated from either B6 (B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv2
2/2) EF4.1 mice. Data are the means 6 SEM (n=9) of 18-hr stimulations
from 3 experiments. (B–C) IL-2 production in response to stimulation with 5610
26 M env124-138L (L), env124-138Y (Y) or env124-138YS (YS) in comparison
with the absence of peptide stimulation (-) of Va2 or non-Va2 env124-138L-reactive hybridoma T cell lines derived from Emv2
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by Emv2 enriched the non-Va2 repertoire for clones with relative
indifference for this position.
Genetic contribution to a high-avidity env124-138L-
reactive CD4
+ T cell repertoire
Analysis of the env-reactive CD4
+ T cell repertoire in B6 mice
revealed a clear effect of Emv2-mediated selection. However, in
addition to Emv2, the presence of numerous other endogenous
retroviruses could affect the formation of the env124-138L-reactive
CD4
+ T cell repertoire, even if their primary amino acid sequence
is not closely homologous with that of F-MLV env. Furthermore,
the functional avidity of env124-138L-reactive CD4
+ T cells could
also be affected by additional genetic determinants other than
endogenous retroviruses. To address this question we generated
congenic EF4.1 mice on the 129S8 background. 129S8 mice share
the same MHC class II allele with B6 mice (H2-A
b), thus allowing
restriction of env124-138L-specific EF4.1 CD4
+ T cells. However,
they do differ substantially with respect to the composition of
endogenous retroviruses and, importantly, 129S8 mice are
naturally devoid of endogenous ecotropic MLVs [34,35]. Similar
frequency of env124-138L-reactive Va2 CD4
+ T cells developed in
B6 and 129S8 EF4.1 mice (Figure 8A). In contrast, the frequency
of env124-138L-reactive non-Va2 CD4
+ T cells was significantly
higher on the 129S8 than on the B6 background (Figure 8A), and
was comparable with that on the Emv2-deficient B6 background
Figure 7. Depth of Va2 or non-Va2 env-specific CD4
+ T cell repertoires. (A–C) Va2 or non-Va env124-138L-reactive hybridoma T cell lines were
derived from Emv2
+/+ (B6-EF4.1) or Emv2
2/2 (B6-EF4.1 Emv2
2/2) EF4.1 mice and tested for reactivity against a library of env126-138 peptide epitopes.
The amino acid residues in positions 128 (A), 129 (B) and 133 (C) that elicited at least 40% of the maximal response are listed in the order of
preference by the individual clones.
doi:10.1371/journal.ppat.1002709.g007
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finding indicated that deletion of env124-138L-reactive non-Va2
CD4
+ T cells in B6, but not in B6-Emv2
2/2 or 129S8 mice was
mediated primarily by Emv2. Surprisingly, however, the functional
avidity of env124-138L-reactive Va2 CD4
+ T cells in 129S8 mice
was very much reduced in comparison with that of Va2 CD4
+ T
cells in B6 mice (Figure 8B), and was as low as that of low-avidity
non-Va2 CD4
+ T cells. As, a result of differences in frequency and
functional avidity, the env124-138L-specific response of 129S8 mice
was dominated by non-Va2 CD4
+ T cells at all peptide doses, in
contrast to that of B6 mice, which was dominated by Va2 CD4
+ T
cells at low peptide doses (Figure 8C).
To further explore the origin of high-avidity env124-138L-
reactive Va2 CD4
+ T cells in B6, but not in 129S8 mice, we
tested the response of a series of B66129S8-EF4.1 F1 mice. In
comparison with B66129S8-EF4.1 F1 mice, which inherited Emv2
from the B6 parent, B6-Emv2
2/26129S8-EF4.1 F1 mice, which
lacked ecotropic MLVs, had elevated frequencies of env124-138L-
reactive non-Va2 CD4
+ T cells, whereas frequencies of env124-
138L-reactive Va2 CD4
+ T cells were similar (Figure 8D). These
results confirmed that elevated frequencies of env124-138L-reactive
non-Va2 CD4
+ T cells in 129S8 mice were indeed due to lack of
Emv2-mediated selection. Interestingly, both B66129S8-EF4.1
and B6-Emv2
2/26129S8-EF4.1 F1 mice generated env124-138L-
reactive Va2 CD4
+ T cells with higher avidity than those of 129S8
mice (Figure 8E), suggesting that a genetic contribution of the B6
parent, other than Emv2, was necessary for the development of
high-avidity env124-138L-reactive Va2 CD4
+ T cells. To assess
whether this genetic contribution arose from polymorphisms in the
Trav locus itself, we tested B6-Tcra
2/26129S8-EF4.1 F1 mice,
which inherited Emv2 from the B6 parent, but could generate
endogenous Va chains only from the locus inherited from the
129S8 parent. The presence of Emv2 in B6-Tcra
2/26129S8-EF4.1
F1 mice had the predicable effect on the frequency of env124-138L-
reactive non-Va2 CD4
+ T cells (Figure 8D), which displayed
comparably low avidity in all three F1 strains tested (Figure 8E).
Surprisingly, however, env124-138L-reactive Va2 CD4
+ T cells that
had developed in B6-Tcra
2/26129S8-EF4.1 F1 mice were also
low-avidity, which was comparable with that of Va2 CD4
+ T cells
in 129S8 mice (Figure 8E), suggesting that the ability of B6 mice to
generate high-avidity env124-138L-reactive Va2 CD4
+ T cells was
germline-encoded. Consequently, the env124-138L-specific response
of B66129S8-EF4.1 F1 mice, but not of isogenic mice lacking
either Emv2 or the B6-origin Trav, was dominated by Va2 CD4
+ T
Figure 8. Genetic contribution to a high-avidity env-reactive CD4
+ T cell repertoire. (A) Frequency of env124-138L- reactive cells in Va2o r
non-Va2 primary CD4
+ T cells isolated from either B6 (B6-EF4.1) or 129S8 (129S8-EF4.1) EF4.1 mice. (B) Functional avidity of env124-138L-reactive Va2o r
non-Va2 primary CD4
+ T cells from the same donors in A. (C) Frequency of Va2 cells in env124-138L-reactive CD4
+ T cells from the same donors in A as
a function of peptide concentration. (D) Frequency of env124-138L- reactive cells in Va2 or non-Va2 primary CD4
+ T cells isolated from either
B66129S8-EF4.1 F1, B6-Emv2
2/26129S8-EF4.1 F1 or B6-Tcra
2/26129S8-EF4.1 F1, EF4.1 mice. (E) Functional avidity of env124-138L-reactive Va2 or non-
Va2 primary CD4
+ T cells from the same donors in D. (F) Frequency of Va2 cells in env124-138L-reactive CD4
+ T cells from the same donors in D as a
function of peptide concentration. Numbers in (B) and (E) represent the ED50. In (C) and (F) the CD4
+ T cell response elicited by the last peptide dose
(10
28 M) was too small to allow accurate measurement of the frequency of Va2 cells and was therefore omitted. Data in (A–F) are the means 6 SEM
(n=4–8) of 18-hr stimulations from 3 experiments.
doi:10.1371/journal.ppat.1002709.g008
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CD4
+ T cells in the env124-138L-reactive population was lower in
B66129S8-EF4.1 F1 mice than in B6 mice, as the former were
expressing endogenous Va chains from both parental Trav loci.
Thus, the combined effect of Emv2 on the frequency of non-Va2T
cells and of Trav on the avidity of Va2 T cells was necessary for the
dominance of high-avidity Va2 CD4
+ T cells in the response to
env124-138L.
Discussion
As a result of the combinatorial process that creates TCRs, their
specificity is random and has to undergo selection. Thymic
positive and negative selection of developing T cells ensures that
mature T cells in the periphery have a functional TCR and
minimal reactivity to self proteins, respectively [36]. Negative
selection is thought to decrease the frequency, avidity and cross-
reactivity of the developing TCR repertoire specific to foreign
epitopes that may be similar to self-derived epitopes presented in
the thymus [36] and promote peptide specificity [37]. Here we
used a well-characterized molecular system to show that negative
selection by a defined self peptide from Emv2 env indeed decreased
the frequency in the naı ¨ve CD4
+ T cell repertoire of clones specific
to a range of foreign env epitopes, thus reducing the magnitude of
the CD4
+ T cell response to all env epitope variants. However,
negative selection counter-intuitively also promoted the avidity of
the CD4
+ T cell response to F-MLV env by shifting the clonal
composition of responding CD4
+ T cells in favor of high-avidity
cells.
CD4
+ T cells play a central coordinating role in the
orchestration of adaptive immunity to infection, and may also
mediate direct antiviral activity. Recent studies in diverse systems
have indicated an essential role for the CD4
+ T cell response in the
control of retroviral infection [15,38–42]. We have previously
shown that protection of wt mice against acute FV infection is
proportional to the frequency of virus-specific CD4
+ T cells [23].
Surprisingly, we found that although negative selection signifi-
cantly reduced both the precursor frequency and peak expansion
of F-MLV env-specific CD4
+ T cells, it did not compromise CD4
+
T cell-mediated antiviral activity. This finding suggested that not
all virus-specific CD4
+ T cells were equal in their ability to
mediate antiviral functions. Indeed, negative selection by Emv2 env
affected CD4
+ T cells with low avidity for F-MLV env, but not
those with high avidity for the same epitope. Preservation of full
antiviral activity in the Emv2-selected CD4
+ T cell repertoire
therefore indicated that this activity is primarily, if not exclusively,
exerted by high-avidity CD4
+ T cells.
High-avidity virus-specific CD4
+ T cells may be superior in
certain direct antiviral or indirect helper functions than low-avidity
ones, but there may also be important exceptions. High-avidity
CD4
+ T cells responding to FV infection have been reported to
show enhanced ex vivo production of IFN-c and IL-21 cytokines
and reduced expression of PD-1 inhibitory receptor [15] than low-
avidity counterparts, properties that may contribute to superior
antiviral activity. However, T follicular helper (Tfh) differentiation
and function were previously found to be similar between high-
and low-avidity virus-specific CD4
+ T cells [15], suggesting that
provision of T cell help for the production of virus-neutralizing
antibodies may be more sensitive to the frequency of virus-specific
CD4
+ T cells, rather than their avidity. However, in addition to
the frequency of virus-specific CD4
+ T cells, the virus-specific
antibody response is also proportional to the frequency of rare
antigen-specific B cells. Thus, when availability of T cell help is
abundant, the virus-specific antibody response may be limited by
the frequency of antigen-specific B cells and additional T cell help
would not be expected to enhance antibody production. Consis-
tent with this idea, adoptive transfer of virus-specific EF4.1 CD4
+
T cells into wt B6 mice did not accelerate the virus-neutralizing
antibody response [23]. In addition to an effect of Emv2 on the
availability of T cell help for the FV-specific antibody response,
Emv2 could in principle also directly affect the development of
virus-specific B cells [43]. Although we observed comparably low
FV-specific antibody responses between B6 and B6-Emv2
2/2 mice
at the peak of FV infection, our results did not exclude a potential
direct effect of Emv2 on FV-specific B cell and antibody responses
at later time-points, when these responses are fully induced.
Indeed, Emv2-encoded env shares 79% amino acid identity with F-
MLV env and it is therefore possible that Emv2 expression,
especially when upregulated, might affect the FV-specific antibody
response.
As previously shown, high-avidity F-MLV env122-141L-specific
Va2 CD4
+ T cells are a minority subset in the naı ¨ve repertoire and
only dominate the immune response to FV as a result of their
preferential expansion during infection [15]. We have now found
that for this ability of high-avidity F-MLV env122-141L-specific
Va2 CD4
+ T cells to dominate the peak response, negative
selection by Emv2 of at least some of the competitor low-avidity F-
MLV env122-141L-specific non-Va2 CD4
+ T cells is necessary.
These findings indicate that even subtle thymic events can have
profound effects on the induction of an effective T cell response to
retroviral infection. Recently, a comprehensive theoretical study
has indicated that HLA class I alleles that associated with control of
HIV infection, such as HLA-B*5701, sample far fewer self peptides
than other HLA alleles [5]. As a result of less stringent negative
selection, a higher frequency of CD8
+ T cells restricted by these
protective alleles were predicted to recognize viral peptide epitopes
and to cross-react with variants of the targeted epitopes [5].
Our results with a single self peptide provide further experi-
mental confirmation of negative selection reducing both the
precursor frequency and cross-reactivity of env-specific CD4
+ T
cells, although in this case the effect on cross-reactivity was more
pronounced at the population, rather than the single-cell level.
These results also suggest that from the thousands of self peptides
that can mediate thymic selection of retrovirus-specific T cells, the
main effects may be mediated by only a few self peptides.
Moreover, self peptides with such strong influence may also be
polymorphic between different individuals, which might contrib-
ute to the partial association of HLA polymorphisms with virus
control [3,5,6].
In addition to polymorphisms at the MHC/HLA locus or of self
peptides mediating thymic selection, the Trav/TRAV and Trbv/
TRBV loci may also display allelic sequence variation. A
polymorphism in the TRBV9 gene has been shown to affect
TCR affinity for and functional recognition of an HLA-B*3501-
restricted epitope from the EBNA-1 protein of Epstein-Barr virus
(EBV), leading to a public T cell response dominated by the high-
affinity variant [44]. Similarly, we found that the ability of Va2
chains to confer high avidity for env122-141L in EF4.1 mice seems
to be germline-encoded, as only Va2 chains encoded by the B6,
but not the 129 Trav locus had this ability. It is tempting to
speculate that amino acid residues unique to the B6-germline
Trav14-encoded Va2 chains participate in recognition of the
strongly interacting L (or a limited set of amino acids with similar
properties) at env position 128. Notably, the CD8
+ T cell response
to an HLA-B8-restricted epitope from the latent antigen EBNA
3A of EBV uses almost exclusively identical Va and Vb, as well as
other TCR-region sequences, and comprehensive structural
studies have shown that a unique amino acid residue in the
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of the preferred Va chain, encoded by TRAV26-2, is critically
required for binding to a residue from the peptide epitope [45].
Despite the vast number of somatically-generated random TCRs
that can arise during T cell development, these studies highlight
the potential for germline-encoded residues to provide exquisite
specificity and competitive advantage to the TCRs that carry
them.
In addition to likely representingthe best-fitforrecognition ofA
b-
restricted env122-141L, the dominance of Va2 EF4.1 CD4
+ T cells
could also result from preferential pairing of the transgenic TCRb
chain with Va2 chains in general. This is unlikely to be the case as
the usage of Va2 cells was not increased in either total or
env122-141L-reactive EF4.1 CD4
+ T cells, and indeed in the env122-
141L-reactive preimmune repertoire clones using other Va chains
were at least 3 times more frequent than those using Va2. However,
although non-Va2 env122-141L-reactive CD4
+ T cells were still the
majority in Emv2-expressing mice, their ability to participate in the
response toFVandcompetewith env122-141L-reactiveVa2 CD4
+T
cells was severely compromised by Emv2. Thus, the dominance of
Va2 CD4
+ T cells in the response to FV infection can be seen as a
combination of germline-encoded advantage in A
b-restricted
env122-141L recognition conferred to Va2 CD4
+ T cells and of
Emv2-mediated self-tolerance of other non-Va2 CD4
+ T cells
capable of recognizing A
b-restricted env122-141L.
One important novel insight of the current study is the proof of
principle that negative selection is not necessarily always impairing
high-avidity T cell responses. By counter-selecting some cross-
reactive CD4
+ T cells, negatively selecting self peptides have the
ability to significantly enhance the avidity for the response to at
least some epitope variants. Higher precursor frequency and cross-
reactivity with emerging epitope variants seem to be the best
correlates for an effective cytotoxic CD8
+ T cell response [5].
Whether higher avidity for the primary infecting epitope, rather
than cross-reactivity with epitope variants better describes an
effective CD4
+ T cell response to retroviral infection needs to be
further addressed.
It should be noted that differences in avidity for antigen in this
system were defined functionally. Indeed, Va2 env122-141L-specific
primary CD4
+ T cells or hybridomas reacted to much lower
concentrations of env122-141L peptide stimulation in vitro than their
non-Va2 counterparts. Furthermore, this higher sensitivity trans-
lated to higher in vivo expansion and increased potential for
cytokine production [15]. It is currently unclear whether
differences in functional avidity between Va2 and non-Va2
env122-141L-specific CD4
+ T cells resulted from overall higher
affinity of individual TCRs of these polyclonal populations for the
peptide-MHC class II complex. Although dissociation kinetics
between TCRs and peptide-MHC class II tetramers are often
informative with respect to the biochemical affinity of these TCRs,
they may not be universally useful. For example, the available
env123-141-A
b tetramer (A
b-env) is known to bind only some
env124-138L-specific CD4
+ T cell clones but not others, irrespective
of their functional avidity or Va usage [14,22]. Therefore, this
reagent could not be used to access the biochemical affinity of all
env124-138L-specific CD4
+ T cells in the polyclonal repertoire.
Furthermore, identification of antigen-specific cells using a
sensitive two-dimensional binding assay has recently demonstrated
that the affinity of many CD4
+ T cells that participate in the
response to two separate antigens is below detection with peptide-
MHC class II tetramers [46]. Thus, peptide-MHC class II
tetramers may generally only detect some but not all antigen-
specific CD4
+ T cells. In addition, such detection is conditional on
expression of sufficient TCR levels. Indeed, we have found that the
extensive, antigen-induced downregulation of their TCR in vivo,
eclipses detection with the A
b-env123-141 tetramer of even the
env122-141L-reactive CD4
+ T cells that could otherwise bind this
reagent. Similar observations have been recently made with
peptide-MHC class I tetramer staining of virus-specific effector
CD8
+ T cells [47], suggesting that the inability of peptide-MHC
multimers to identify antigen-specific effector T cells that have
downregulated their TCRs may be a general problem for T cells
restricted by both classes of MHC molecules.
Negative selection ensures minimal reactivity of developing
thymocytes to self proteins. However, endogenous retroviruses are a
large constituent of mammalian genomes and thus represent a
potentially large pool of self proteins able to mediate selection, both
positive and negative. Self peptides encoded by endogenous MLVs
have been shown to mediate positive selection of CD4
+ T cells with
specificity for an unrelated H2-E
k-restricted moth cytochrome C
peptide, and to enhance the response of mature CD4
+ T cells with
this specificity in the periphery [48]. We found that Emv2 was
expressed at very low levels in the thymus of B6 mice, in agreement
with a previous report [49], and was undetectable by qRT-PCR in
some of the mice. It should be noted, however, that the qRT-PCR
method employed was specific only for the spliced env mRNA that is
transcribed by Emv2. This was chosen to eliminate the possibility of
detecting contaminating genomic DNA or viral genomic RNA, but
may underestimate the total amount of spliced and unspliced
mRNA that leads to the production of other viral proteins.
Nevertheless, as demonstrated by its effect on thymic development,
this low level of Emv2 expression was clearly functional.
Endogenous retroviruses have been known for many years to
cause a range of different diseases in mice, including cancer,
immunodeficiency and autoimmunity, although a similar causal
effect in humans has been questioned [50]. Immune reactivity to
endogenous retroviruses has been amply demonstrated in mice
where is has been strongly associated with the development of
spontaneous autoimmune conditions [51,52]. Interestingly, immune
reactivity to endogenous retroviruses has also been frequently
observed in humans during infection, inflammation, autoimmunity
and cancer [50,53–56]. Expression of human endogenous retrovi-
ruses, as well as CD8
+ T cell responses against their antigens, have
been documented in HIV infection [57,58]. Furthermore, a whole-
genome association study has suggested that part of the effect of the
protective HLA-B*5701 allele during the asymptomatic period of
HIV infection may be mediated by a linked human endogenous
retrovirus at the same locus [59]. Human endogenous retroviral
antigens have also been reported to serve as targets for CD8
+ Tc e l l -
mediated rejection of cancer cells [60]. It might be evident from the
studies in humans and the results of the current study that peptide
epitopesencoded byendogenousretroviruseshavea strong influence
on T cell thymic selection and may also participate in the shaping of
the peripheral T cell response. It is also clear that endogenous
retroviruses do not always cause immunological tolerance, and
although their activation in infected or transformed cells may
provide a non-mutable target for immune attack, activation of
endogenous retroviruses may also trigger inflammatory or autoim-
mune phenomena frequently associated with infection and cancer.
Further study of endogenous retrovirus regulation during infection,
autoimmunity or cancer, and of the immune responsiveness to them
should shed more light into their pathogenic potential.
Materials and Methods
Ethics statement
All animal experiments were approved by the ethical committee
of the NIMR, and conducted according to local guidelines and
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Procedures Act 1986 (ASPA).
Mice




+ B6) mice were originally obtained from The Jackson
Laboratory (Bar Harbor, Maine, USA) and were subsequently
maintained at NIMR animal facilities. Inbred 129S8/SvEvNimrJ
(129S8) miceweredevelopedfrom an129/Svsubstrain,maintained
at NIMR animal facilities, and were subsequently deposited at The
Jackson Laboratory. The B6 TCRb-transgenic strain EF4.1,
expressing a transgenic TCRb chain from a T cell clone specific
to F-MuLV env122-141 presented by H2-A
b, has been described
[14]. 129S8-congenic EF4.1 mice were generated by serial
backcrossing of B6-EF4.1 mice for 10 nuclear generations onto
the 129S8 genetic background. B6-backcrossed Rag1-deficient
(Rag1
2/2) mice [61] and T cell receptor a-deficient (Tcra
2/2) mice






2/2) mice have been previously
described [25]. Emv2-deficient (Emv2
2/2) B6 mice were created by
introducingtheEmv2integrationsiteofchromosome8fromtheA/J
strain, which lacks this proviral integration, by serial backcrossing
for at least 12 nuclear generations onto the B6 genetic background.
Lack of Emv2 was validated by PCR for both the D8Mit49
microsatellite marker close to the locus that detects polymorphisms
in A/J (Emv2
2) and B6 (Emv2
+) strains of mice (D8Mit49 forward 59-
TCTGTGCATGGCTGTGTATG-39 and D8Mit49 reverse 59-
TGGTGTGCTGCTGATGCT-39), and also for the actual inte-
gration site using three primers, two of which were flanking the
integration site (forward 59-ACCCACTAAGTAACCCAG-
GCTGCCTCAGCT-39 and reverse 59-GACCAGAATAGAAA-
GACGTTCAAGTGAGCT-39) and one located in the Emv2 LTR
(59-ATCAGCTCGCTTCTCGCTTCTGTACCCGCG-39) (Fig-
ure S3).
In vitro T cell activation
Spleen or lymph node single-cell suspensions were prepared
from EF4.1 mice and 5610
5 cells per well were stimulated in 96-
well plates with the indicated amount of env peptide variants. The
frequency of env-reactive cells in stimulated CD4
+ T cells was
defined as the frequency of cells that responded to 18-hr
stimulation, before cell division or death had occurred, by
upregulating CD69 expression. Correct identification of env-
reactive CD4
+ T cells by CD69 upregulation was confirmed in
control experiments by co-staining for CD154 (CD40L) expression
in stimulated T cells. Both antibodies were obtained from
eBiosciences. For assessment of T cell activation on day 3, cells
were labeled with CFSE before stimulation and responding cells
were identified by CFSE dilution.
Hybridoma cell line generation and stimulation
Single-cell suspensions were prepared from spleens and lymph
nodes from Emv2-sufficient or -deficient EF4.1 mice and stimu-
lated in vitro with 10
27 Mo r1 0
25 M env122-141L peptide and
4 ng/ml recombinant human IL-2 for 4 days. CD4
+ T cells were
subsequently purified from stimulated cultures using immuno-
magnetic positive selection (StemCell Technologies, Vancouver,
BC, Canada) and fused to TCRab-negative BW5147 thymoma
cells to produce hybridoma cell lines. Established hybridoma cell
lines were stimulated with a range of env peptide variants
presented by dendritic cells. Dendritic cells were obtained from
cultures of bone marrow cells isolated from B6 mice and
supplemented with granulocyte macrophage colony-stimulating
factor (GM-CSF). GM-CSF was obtained from culture superna-
tant of663 cells transfected with mouse Csf2 and was used at 1:10
dilution. Bone marrow cells were culture in these conditions for 7
days, at which point they consisted of 50–70% dendritic cells.
These cells were then used to stimulate hybridoma cells at a ratio
of 5610
4 dendritic cells to 1610
5 hybridoma cells, for 18 hrs, in
the presence or absence of env peptide variants. Dendritic cell-
hybridoma cell co-cultures were plated in flat-bottom 96-well
plates in 200 ml final volume. The concentration of peptides used
is indicated in individual figures and figure legends. In additional
experiments peritoneal macrophages were also used as antigen-
presenting cells with results comparable to the use of dendritic
cells. Macrophages were isolated from B6 mice following plating of
the peritoneal cavity exudate cells for 1 hr and washing off the
non-adherent fraction. Env-specific responses were assessed by
measuring the amount of IL-2 secreted in co-culture supernatants
using an AlamarBlue (Invitrogen, Carlsbad, CA, USA)-based
CTLL-2 assay.
Tra gene usage
Trav and Traj usage by T cell hybridomas was probed by
staining with an anti-Va2 (clone B20.1) or anti-Va3.2 (clone RR3-
16) monoclonal antibodies, and by reverse transcription (RT)-PCR
amplification and sequencing of expressed Trav genes, using
previously described primers [63]. Trav and Traj segment
identification and alignment, and confirmation of productive
rearrangements were performed on the International Immunoge-
netics Information System website (http://www.imgt.org).
Viruses and infections
The FV used in this study was a retroviral complex of a
replication-competent B-tropic F-MuLV and a replication-defec-
tive polycythemia-inducing spleen focus-forming virus (SFFVp).
Stocks were propagated in vivo and prepared as 10% w/v
homogenate from the spleen of 12-day infected BALB/c mice.
Mice received an inoculum of ,1,000 spleen focus-forming units
of FV. All viral stocks were free of Sendai virus, Murine hepatitis
virus, Parvoviruses 1 and 2, Reovirus 3, Theiler’s murine
encephalomyelitis virus, Murine rotavirus, Ectromelia virus,
Murine cytomegalovirus, K virus, Polyomavirus, Hantaan virus,
Murine norovirus, Lymphocytic choriomeningitis virus, Murine
adenoviruses FL and K87, and Lactate dehydrogenase-elevating
virus. Virus inocula were injected via the tail vein in 0.1 ml of
phosphate-buffered saline. FV-infected cells were detected by flow
cytometry using surface staining for the glycosylated product of the
viral gag gene (glyco-Gag), using the matrix (MA)-specific
monoclonal antibody 34 (mouse IgG2b), followed by an anti-
mouse IgG2b-FITC secondary reagent (BD, San Jose, CA, USA).
For the assessment of anemia, mice were bled by a small incision
of the tail vein and blood was collected into heparinized capillary
tubes. Complete blood counts were measured on a VetScan HMII
hematology analyzer (Abaxis, CA, USA), following the manufac-
turer’s instructions. RBC counts of uninfected mice were
,9.95610
6 per mm
3 of blood. FV-induced splenomegaly in
infected mice was expressed as spleen index, which is the ratio of
the weight of the spleen (in mg) to the weight of the rest of the
body (in g).
FV-neutralizing and F-MLV-infected cell-binding antibody
assays
Serum titers of FV-neutralizing antibodies were measured as
previously described [25]. The dilution of serum which resulted in
75% neutralization was taken as the neutralizing titer. Serum titers
of F-MLV-infected cell-binding antibodies were determined by
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dunni cells with serial dilutions of serum samples and secondary
staining with fluorescently labeled anti-mouse IgG1 (clone A85-1),
anti-mouse IgG2a/c (clone R19-15), anti-mouse IgG2b (clone
R12-3) or anti-mouse IgM (clone R6-60.2) antibodies (BD). B6
mice express the IgG2c isotype, which may not be efficiently
detected by anti-IgG2a reagents [64]. Although the R19-15
monoclonal antibody has higher affinity for IgG2a, it can be
effectively used for detection of IgG2c. This was confirmed by
staining of F-MLV-infected Mus dunni cells that were first
incubated with serum from FV-infected mice, with the anti-IgG1
or anti-IgG2a/c or anti-IgG2b reagents separately (Figure S8A).
The three reagents used separately resulted in comparable staining
intensity, which allowed us to use all three IgG subclass-specific
antibodies in combination. For IgG titers, F-MLV-infected Mus
dunni cells were first incubated with serum samples and then with
anti-IgG1, anti-IgG2a/c and anti-IgG2b antibodies mixed togeth-
er. Serum samples were 2-fold serially diluted, starting from an
initial dilution of 1:50. The last positive serum dilution resulting in
staining intensity at least twice the background level was taken as
the binding titer (Figure S8B).
T cell purification and adoptive transfer
Single-cell suspensions were prepared from the spleens and
lymph nodes of donor CD45.2
+ EF4.1 mice by mechanical
disruption. Spleen suspensions were treated with ammonium
chloride for erythrocyte lysis. CD4
+ T cells were enriched using
immunomagnetic positive selection (StemCell Technologies)
according to the manufacturer’s instructions. Purity of the isolated
CD4
+ T-cell population was routinely higher than 92%. A total of
approximately 1610
6 EF4.1 CD4
+ T cells were injected in B6-
congenic CD45.1
+CD45.2
+ recipients via the tail vein in 0.1 ml of
air-buffered Iscove’s Modified Dulbecco’s Media. When adoptive
transfer of CD4
+ T cells was combined with FV infection, purified
CD4
+ T cells and virus stocks were injected separately into
recipient mice within a 24 hour-period.
Flow cytometry
Spleen-cell suspensions were stained with directly-conjugated
antibodies to surface markers, obtained from eBiosciences (San
Diego, CA, USA), CALTAG/Invitrogen, BD Biosciences (San
Jose, CA, USA) or BioLegend (San Diego, CA, USA). Donor-type
env-specific CD4





+ cells. Four- and 8-color cytome-
try were performed on FACSCalibur (BD Biosciences) and CyAn
(Dako, Fort Collins, CO) flow cytometers, respectively, and
analyzed with FlowJo v8.7 (Tree Star Inc., Ashland, OR, USA)
or Summit v4.3 (Dako) analysis software, respectively.
Emv2 expression by quantitative reverse transcription
(qRT)-PCR
Total RNA was extracted from whole organs using TRI-reagent
(Sigma-Aldrich, St. Louis, US) according to the manufacturer’s
instructions, precipitated with isopropanol and washed in 75%
ethanol before being dissolved in water. DNase digestion and
cleanup was performed with the RNeasy Mini Kit (Qiagen,
Hilden, Germany) and cDNA produced with the high capacity
reverse transcription kit (Applied Biosystems, Carlsbad, US) with
an added RNase inhibitor (Promega Biosciences, Madison, US). A
final clean-up was performed with the QIAquick PCR purification
kit (Qiagen). Level of expression of Emv2 RNA was determined by
qRT-PCR using DNA Master SYBR Green I kit (Roche,
Mannheim, Germany) and the ABI Prism 7000 or 7900HT
Detection System (TaqMan, Applied Biosystems, Foster City, CA).
The following primers were used for the amplification of target
transcripts: Hprt: forward 59-TTGTATACCTAATCATTA-
TGCCGAG-39 and reverse 59- CATCTCGAGCAAGTCT-
TTCA-39; Emv2: forward 59-CCAGGGACCACCGACCCA-
CCGT-39 and reverse 59-TAGTCGGTCCCGGTAGGCC-
TCG-39. Emv2-specific primers amplified only the spliced form
of env mRNA, thus eliminating the possibility of residual genomic
DNA or RNA contamination contributing to Emv2 signal. The
housekeeping gene Hprt was used to normalize the Critical
Threshold (CT) values for Emv2. Analysis was conducted with the
DCT method [65] and Emv2 expression corresponding to an Emv2
CT value of 40 (the total number of amplification cycles used) was
set at 1 arbitrary unit. A theoretical detection limit of 2 arbitrary
units was also used, which represents the detectable Emv2 signal in
the penultimate cycle of amplification.
Statistical analysis
Statistical comparisons were made using SigmaPlot 12.0 (Systat
Software Inc., Germany). Parametric comparisons of normally-
distributed values that satisfied the variance criteria were made by
unpaired Student’s t-tests. Linear percentages of FV-infected cells,
spleen indices and nAb titers, which did not pass the variance test,
were compared with non-parametric two-tailed Mann-Whitney
Rank Sum or Wilcoxon Signed Rank tests.
Accession numbers
N Cd4 cluster of differentiation 4 antigen [Mus musculus]; Gene
ID: 12504; Protein ID: NP_038516.1
N Rag1 recombination activating gene 1 [Mus musculus]; Gene ID:
19373; Protein ID: NP_033045.2
N Fv2 Friend virus susceptibility 2 [Mus musculus]; Gene ID:
19882; Protein ID: NP_033100.1
N Tcra T cell receptor alpha chain [Mus musculus]; Gene ID:
21473
N Tcrb T cell receptor beta chain [Mus musculus]; Gene ID: 21577
N Emv2 endogenous ecotropic MuLV 2 [Mus musculus]; Gene ID:
111372
N env envelope protein [Friend murine leukemia virus]; Gene ID:
1491875; Protein ID: NP_040334.1
Supporting Information
Figure S1 Effect of N-terminal epitope length on TCR
recognition by primary and hybridoma EF4.1 envL-
specific CD4
+ T cells. (A) Frequency of CD69
+ cells in Va2o r
non-Va2 CD4
+ T cells (expressed as percentage of the maximal
response elicited by the env122-141L peptide), following 18-hr in
vitro stimulation of spleen cell suspensions from EF4.1 mice with
the indicated range of N-terminal truncated envL peptides. (B) IL-
2 production in the supernatant of hybridoma cells lines
established from Va2 or non-Va2 env-specific EF4.1 CD4
+ T
clones following 24-hr in vitro stimulation with the indicated range
of N-terminal truncated envL peptides. Data are pooled from 3
separate experiments.
(PDF)
Figure S2 Sequence and TCR SB14-31 contact residues
of F-MLV- and Emv2-encoded env123-140. (A) Amino acid
sequence, in single-letter code, of env123-140 encoded by either F-
MLV or Emv2. Differences in sequence are indicated by red color.
(B) Important contact residues for the SB14-31 TCR (indicated in
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b (indicated in blue) in F-MLV-encoded env123-
140L. Numbers underneath amino acid residues correspond to
amino acid positions in env.
(PDF)
Figure S3 Chromosomal location of Emv2 in B6 mice
and screening of Emv2
2/2 B6 mice. Emv2 is integrated near
the telomere of Chromosome 8 of B6 mice in reverse orientation
relative to the forward strand, between the Tubb3 and Def8 genes
(Search for Mela on http://www.ncbi.nlm.nih.gov/mapview), and
it is absent from A/J mice. Lack of Emv2 on Emv2
2/2 congenic B6
mice is shown by PCR for the actual integration site (red arrows)o r
for the polymorphic D8Mit49 microsatellite marker that is further
telomeric with respect to Emv2 (not shown on map).
(PDF)
Figure S4 Effect of Emv2 on the endogenous CD4
+ T
cell, CD8
+ T cell and antibody responses. B6 and B6-
Emv2
2/2 mice were infected with FV and their adaptive responses
were measured 7 days later. T cell responses were measured in
cells isolated from the spleens and antibody responses from the
sera of these mice. (A) Percentage of CD44
hiCD43
+ cells in total
CD8
+ T cells. (B) Percentage of Va3.2
+Vb5.2
+ cells in either
CD44
hi (left) or CD44
lo (right) CD8
+ T cells. The dashes horizontal
line represents the same frequency in uninfected control mice. The
dashed horizontal lines in (A) and (B) represent the depicted
frequencies in uninfected control mice. (C) Serum titers of F-
MLV-infected cell-binding IgG (left) and IgM (right). Dashed lines
represent the limit of detection. (D) Percentage of A
b-env123-141
tetramer
+ cells in total CD4
+ T cells. Horizontal short lines denote
the median frequencies and the dashed line denotes the median
frequency of A
b-hCLIP (control) tetramer
+ cells in the same




+ T cells from the same mice. The dashed horizontal line
represents the frequency of Va2 cells in total CD4
+ T cells from
the same mice. In (A) to (E) each symbol represents an individual
mouse.
(PDF)
Figure S5 Gating strategy for the identification of env-
specific donor CD4





6) were adoptively transferred into wild-type Ptprc
1/2 B6
recipients that were infected with FV the same day. Host cells were
identified as CD45.1 CD45.2 double-positive whereas donor cells
were CD45.2 single-positive.
(PDF)
Figure S6 Effect of Emv2 on the frequency and compo-




2/2 EF4.1 mice were stimulated for
18 hrs in vitro with the indicated amount of env124-13L peptide
presented by bone marrow-derived dendritic cells and responding
cells were identified by upregulation of CD69 expression.
Frequency of responding (CD69
+) cells in gated CD4
+ thymocytes
(left) and frequency of Va2 cells in env124-13L-specific cells (right)i s
shown, with p,0.006 and p,0.002, respectively, for 10
26 M
peptide concentration. Results are the means 6 SEM (n=8–10).
(PDF)
Figure S7 Depth of env epitope recognition by Emv2-
selected and -nonselected T cell hybridomas. Va2 or non-
Va2 (Va3) env124-138L-reactive T cell hybridomas were established
from Emv2
+/+ or Emv2
2/2 EF4.1 mice and tested for reactivity
against a library of env126-138 peptide epitopes (at 5610
26 M
concentration), in which positions 128, 129 and 133 were
individually replaced by all natural amino acids. The response of
each clone was measured by secretion of IL-2 and is expressed as a
percentage of the maximal response obtained with the most potent
variant. Results are the means of triplicate cultures.
(PDF)
Figure S8 Determining titers of F-MLV-infected cell-
binding antibodies. (A) Mus dunni cells, chronically infected
with F-MLV, were stained with an 1:50 dilution of pooled serum
samples from wt B6 mice that were infected with FV 35 days
earlier (serum sample) or with a dilution of the anti-gp70 of F-
MLV monoclonal antibody 48 (mAb 48; IgG2a) that gives similar
in vitro FV neutralization as 1:50 dilution of the serum sample.
Cells stained with the serum sample were subsequently stained
with anti-IgG1, anti-IgG2a/c or anti-IgG2c antibodies separately
or with all three antibodies mixed together, and cells stained with
mAb 48 were stained with anti-IgG2a/c. Black-filled histograms
show staining with both primary and secondary antibodies, and
gray-shaded histograms show staining with the secondary antibody
only. Note comparable staining intensity between all three IgG
subclass-specific antibodies used separately as secondary reagents
in combination with the serum sample and also in comparison
with the mAb 48. (B) Example of titer determination. Experimen-
tal serum samples were serially diluted 2-fold (starting from 1:50)
and used for staining F-MLV-infected Mus dunni cells. The median
fluorescent intensity (MFI) of co-staining with all three IgG
subclass-specific antibodies at the same time is plotted against the
serum dilution. The horizontal dashed line represents the MFI of
unstained cells. Data were fitted to a sigmoidal curve. The red
lines connect the MFI that is twice the background level and the
serum dilution that results in that MFI. The inverse of the serum
dilution that results in an MFI at least twice the background level
was taken as the titer. This was preferred over titer determination
based on half the maximal response, as in none of the samples
were an obvious maximum (plateau of the curve) reached.
(PDF)
Table S1 Va3.2 expression (determined by FACS), Trav
and Traj segment usage, and amino acid residues at the




Table S2 Va3.2 expression (determined by FACS), Trav
and Traj segment usage, and amino acid residues at the
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